Navigation Links
MIGENIX Reports First Quarter Fiscal Year 2008 Financial Results
Date:9/11/2007

- -

Issuance of convertible royalty participation units - 7,737

Proceeds on exercise of stock options - 1

Proceeds on exercise of warrants 36 17

Repayment of capital lease obligation - (5)

-------------------------------------------------------------------------

Cash provided by financing activities $ 36 $ 7,750

-------------------------------------------------------------------------

Funds from (purchases of) short-term investments 6,880 (1,364)

Proceeds on disposal equipment 12 -

Purchases of equipment (75) (72)

-------------------------------------------------------------------------

Cash provided by (used in) investing activities $ 6,817 $ (1,436)

-------------------------------------------------------------------------

Increase in cash and cash equivalents $ 4,431 $ 3,206

Cash and cash equivalents, beginning of period 2,945 5,743

-------------------------------------------------------------------------

Cash and cash equivalents, end of period $ 7,376 $ 8,949

-------------------------------------------------------------------------

About MIGENIX

MIGENIX is committed to advancing therapy, improving health, and enriching life by developing and commercializing drugs primarily in the area of infectious diseases. The Company's clinical programs include drug candidates for the treatment of chronic hepatitis C infections (Phase II and preclinical), the prevention of catheter-related infections (Phase III) and the treatment of dermatological diseases (Phase II). MIGENIX is headquartered in Vancouver, British Columbia, Canada with US operations in San Diego, C
'/>"/>

SOURCE MIGENIX Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. TomoTherapy reports 86% revenue jump, $131M net loss in Q1
2. Sonic Foundry reports GAAP loss as Q2 revenues rise
3. Fiserv reports $113.5 million in Q1 profit
4. Third Wave reports net loss of $18.9M for 2006
5. Musicnotes reports 45 percent growth in 2006
6. Sonic Foundry reports net loss, higher revenue
7. Sonic Foundry reports first cash-positive quarter
8. Merge Healthcare reports $10.8M net loss in Q3
9. Third Wave reports $5.2M third quarter loss
10. Merge Healthcare appoints new CEO, reports $215 million Q2 loss
11. Merge files financial reports by market opening
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... group leader Yung-Eun Sung has announced that they ... nitrogen-doped graphenes which can be applied as high ... Yung-Eun Sung is both a group leader at ... Basic Science* (IBS) and a professor at the ... significance with regards to the development of relative ...
(Date:7/24/2014)... , July 24, 2014 Research ... "Global Cell Culture Market 2014-2018" report to ... Cell culture is the in vitro growth ... as research, cell studies, and biopharmaceutical production. Cell culture ... production. Cell culture instruments and cell culture consumables are ...
(Date:7/24/2014)... 2014  CorMedix Inc. (NYSE MKT: CRMD), a ... products for the prevention and treatment of cardiorenal ... on July 18, 2014 from the NYSE MKT ... CorMedix plan to regain compliance with continued listing ... NYSE-MKT is continuing the Company,s listing and has ...
(Date:7/24/2014)... PRINCETON, N.J. , July 24, 2014 /PRNewswire/ ... largest provider of regulatory and ethical review services ... acquired Alliance Biosciences. Formerly a division of ... Biosciences was the leading biosafety and biosecurity consulting ... . With this addition, WCG,s biosafety division – ...
Breaking Biology Technology:Global Cell Culture Market 2014-2018: Key Vendors are Becton, Dickinson and Co, EMD, GE Healthcare, Lonza Group, Sigma Aldrich and Thermo Fisher Scientific 2CorMedix, Inc. Granted Extension of NYSE-MKT Listing 2CorMedix, Inc. Granted Extension of NYSE-MKT Listing 3WIRB-Copernicus Group Announces Acquisition of Alliance Biosciences; Executives Join WCG Biosafety Division 2WIRB-Copernicus Group Announces Acquisition of Alliance Biosciences; Executives Join WCG Biosafety Division 3
... Md. , May 18 OriGene Technologies, Inc. with the ... build one of the largest and most sophisticated monoclonal antibody production centers ... production facility is expected to have over one thousand employees with the ... , , ...
... The ... of genetics and molecular biology rapidly expands, a personalized approach to medical care is ... ... set to revolutionize the healthcare industry. As our knowledge of genetics and molecular biology ...
... , ... Gilson, Inc. has selected EDL Consulting’s CloudCraze product to build an enterprise-class, cross-channel ... Built on the Force.com platform and utilizing EDL’s CloudCraze eCommerce product, the ... to customers across Europe. , ...
Cached Biology Technology:OriGene Technologies, Inc. to Build the World's Largest TrueMAB(TM) Monoclonal Antibody Facility in Wuxi, China 2Arrowhead Releases New Report Assessing State of Personalized Medicine Market 2Arrowhead Releases New Report Assessing State of Personalized Medicine Market 3Gilson, Inc. Selects EDL Consulting's CloudCraze For Cross-Channel Webstore Expansion in Europe 2Gilson, Inc. Selects EDL Consulting's CloudCraze For Cross-Channel Webstore Expansion in Europe 3
(Date:7/24/2014)... Bushmeat, the use of native animal species for food ... be a significant factor in the decline of many ... new study indicates that more than half of the ... raptors and hornbills., "By surveying not only the meat ... being eaten inside the forest by hunters and brought ...
(Date:7/24/2014)... identified two factors that characterize sustainable university and ... highly qualified physics teachers. Specifically, one or more ... education in combination with institutional motivation and commitment ... Technology, Engineering and Math (STEM) teacher shortages are ... the way for institutions seeking to increase the ...
(Date:7/24/2014)... sticky research out of York University shows a surprisingly ... toxic grass fungus: moose saliva (yes moose saliva). ... "Ungulate saliva inhibits a grassendophyte mutualism" shows that moose ... (which hosts a fungus called epichlo festucae that produces ... less toxicity. , "Plants have evolved defense mechanisms to ...
Breaking Biology News(10 mins):Creating sustainable STEM teacher preparation programs 2Moose drool inhibits growth of toxic fungus: York U research 2
... New research published in the August 2005 issue ... methamphetamine abuse and HIV infection cause significant alterations ... in both cases the changes may be associated ... learning new information, solving problems, maintaining attention and ...
... in our bodies through a complex network of lymphatic ... however, of major importance for the support of the ... from the Flanders Interuniversity Institute for Biotechnology (VIB) connected ... to indicate that this network can be studied with ...
... of voices they hear to the number of faces ... The finding indicates that numerical perception is truly an ... particular sense, said the researchers. The experimental approach also ... before they have a verbal capacity, understand similar abstract ...
Cached Biology News:Methamphetamine Abuse, HIV Infection Cause Changes in Brain Structure 2Methamphetamine Abuse, HIV Infection Cause Changes in Brain Structure 3Tadpole soon to help in the fight against cancer and lymphedema 2Tadpole soon to help in the fight against cancer and lymphedema 3Monkeys understand numbers across senses 2
From formula-fed bovine calves Sterile, Cell culture tested...
... is a thermostable DNA polymerase derived ... at temperatures above 70°C, it was ... PCR and remains the predominant enzyme ... an intrinsic 5'?3' structure-dependent exonuclease activity, ...
Mouse monoclonal [YPF19] to Yersinia pestis F1 antigen ( Abpromise for all tested applications)....
... This high pressure gradient system uses ... pumps, each providing a flow rate in one ... wavelength detector for added flexibility. System control ... processing software and interface unit, CE 4900., Column ...
Biology Products: